Jeea Lee

Dr. Jeea Lee


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HPHyung Seok Park
Hyung Seok Park
JLJeea Lee
Jeea Lee
DLDong Won Lee
Dong Won Lee
SSSeung Yong Song
Seung Yong Song
DLDae Hyun Lew
Dae Hyun Lew
YCYoung Up Cho
Young Up Cho
Seeking smaller and indistinct incisions, physicians have attempted endoscopic breast surgery in breast cancer patients. Unfortunately, there are some limitations in the range of movement and visualization of the operation field. Potentially addressing these limitations, we investigated the outcomes of gas and gasless robot-assisted nipple-sparing mastectomy (RANSM) with immediate breast reconstruction (IBR). Ten patients underwent 12 RANSM with IBR between November 2016 and April 2018. Patients with tumors measuring >5 cm in diameter, tumor invasion of the skin or nipple-areolar complex, proven metastatic lymph nodes, or planned radiotherapy were excluded. Age, breast weight, diagnosis, tumor size, hormone receptor status, and operation time were retrospectively collected. Postoperative outcomes including postoperative complications and final margin status of resected were analyzed. The median total operation time and console time were 351 min (267–480 min) and 51 min (18–143 min), respectively. The learning curve presented as a cumulative sum graph showed that the console time decreased and then stabilized at the eighth case. There was no open conversion or major postoperative complication. One patient had self-resolved partial nipple ischemia, and two patients experienced partial skin ischemia. We deemed that RANSM with IBR is safe and feasible for early breast cancer, benign disease of the breast, andBRCA 1/2mutation carriers. RANSM is an advanced surgical method with a short learning curve.

1 January 2020 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
HPHyung Seok Park
Hyung Seok Park
JLJeea Lee
Jeea Lee
HLHaemin Lee
Haemin Lee
KLKwanbum Lee
Kwanbum Lee
SSSeung Yong Song
Seung Yong Song
ATAntonio Toesca
Antonio Toesca
Park HS, et al. J Breast Cancer. 2020 Feb;23(1):107-112. https://doi.org/10.4048/jbc.2020.23.e3

27 May 2022 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
JGJieon Go
Jieon Go
JAJee Hyun Ahn
Jee Hyun Ahn
JPJung Min Park
Jung Min Park
CSCHOI SOONBO
CHOI SOONBO
JLJeea Lee
Jeea Lee
HPHyung Seok Park
Hyung Seok Park

1 July 2020 in Asian Journal of Surgery
Verified
Journal Article
Open access
KYKwang Hyun Yoon
Kwang Hyun Yoon
BKBonyong Koo
Bonyong Koo
KLKwan Beom Lee
Kwan Beom Lee
HLHaemin Lee
Haemin Lee
JLJeea Lee
Jeea Lee
BPByeong-Woo Park
Byeong-Woo Park
Pseudoangiomatous stromal hyperplasia (PASH) is a benign mesenchymal proliferative lesion of the breast. Owing to the rarity of PASH, the pathogenesis, clinical manifestation, and optimal treatment of this condition remain unclear. We aimed to clarify the appropriate management of PASH. We performed a retrospective analysis of the clinicopathological data of 66 cases with a diagnosis of PASH, confirmed by core needle biopsy (CNB) or surgical excision at Severance Hospital between 2000 and 2016. The primary endpoint was pathologic results after surgical excision of the lesion that confirmed PASH by CNB. The secondary endpoint was progression after the first treatment. The median age of patients was 41 years (range, 14-61 years). Findings on medical imaging were nonspecific. CNB was performed in 61 cases, with a diagnosis of PASH confirmed in 39 cases (63.9%). No malignant or premalignant cells directly arising from PASH were identified after surgical excision that confirmed PASH via CNB. The progression rate after the first treatment was 16.6%, with lesion size, enlargement of palpable mass size, and a diagnosis other than PASH on CNB being factors associated with progression. CNB is sufficient to confirm PASH what is necessary for an abnormal imaging or suspicious physical examination finding. Surgical excision is not necessarily indicated to rule out occult malignancy after a diagnosis of PASH. Close monitoring or surgical excision are required to manage large lesions (>3 cm) or progressive growth of a PASH lesion.

27 January 2023 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
ATAntonio Toesca
Antonio Toesca
HPHyung Seok Park
Hyung Seok Park
JRJai Min Ryu
Jai Min Ryu
YKYeon Jin Kim
Yeon Jin Kim
JLJeea Lee
Jeea Lee
PVPaolo Veronesi
Paolo Veronesi
Dear Editor

1 January 2021 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
HLHaemin Lee
Haemin Lee
JLJeea Lee
Jeea Lee
KLKwanbum Lee
Kwanbum Lee
JKJee Ye Kim
Jee Ye Kim
HPHyung Seok Park
Hyung Seok Park
Lee H, et al. J Breast Cancer. 2021 Apr;24(2):183-195. https://doi.org/10.4048/jbc.2021.24.e20